TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Blood Transfusion Diagnostics Market – By Product
1.3.2 North America Blood Transfusion Diagnostics Market – By Application
1.3.3 North America Blood Transfusion Diagnostics Market – By End User
1.3.4 North America Blood Transfusion Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Blood Transfusion Diagnostics Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Rise in Chronic Diseases
5.1.2 Growing Need for Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
5.2.1 Problems associated with Blood Transfusion Services
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.4 Future Trends
5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis
6. Blood Transfusion Diagnostics Market– North America Analysis
6.1 North America Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
7. North America Blood Transfusion Diagnostics Market Analysis – By Product
7.1 Overview
7.2 North America Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
7.3.1 Overview
7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8. North America Blood Transfusion Diagnostics Market Analysis – By Application
8.1 Overview
8.2 North America Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
8.3.1 Overview
8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
8.4.1 Overview
8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9. North America Blood Transfusion Diagnostics Market Analysis – By End User
9.1 Overview
9.2 North America Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
9.3.1 Overview
9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
9.6.1 Overview
9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
10. North America Blood Transfusion Diagnostics Market Analysis – Country Analysis
10.1 Overview
10.1.2 North America: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.2.1.3 US: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.2.1.4 US: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Grifols, S.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Immucor, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin S.p.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Quotient Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAG Diagnostics GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms